印度药业公司将以每股1,475元的价格回购8亿美元. Aurobindo Pharma launches ₹800 crore share buyback at ₹1,475 per share.

印度药业公司正在发起8亿卢比的回购计划, 每股价格为1,475卢比. Aurobindo Pharma is launching an ₹800 crore share buyback, offering to purchase shares at ₹1,475 each. 招标将于4月23日开始,并持续至4月29日. The tender offer opens on April 23 and runs through April 29, with a settlement expected by May 7. 公司的目标是通过更高的小股东接受率来提高零售投资者的参与度. The company aims to enhance retail investor participation with a higher acceptance ratio for small shareholders.